184 results on '"Hayney, Mary S."'
Search Results
2. Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study
3. Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines
4. Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease
5. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study
6. Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease—time for universal recommendation? Authors' reply
7. Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease
8. High Uptake of Three COVID-19 Vaccine Doses Among Liver Transplant Recipients
9. Cost‐effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease
10. Characteristics of U.S. older adult medicare beneficiaries receiving the influenza vaccination at retail pharmacies
11. Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
12. Reply to “Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination”
13. Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States
14. A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease
15. Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination
16. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients
17. We Should Not Forget About Patients With Inflammatory Bowel Disease Who Received a COVID-19 Viral Vector Vaccine
18. High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
19. Mo1483: LOW PREVALENCE OF SERIOUS INFECTIONS DUE TO VACCINEPREVENTABLE DISEASES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
20. Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
21. Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease
22. Cell-Mediated Immune Response after COVID 19 Vaccination in Patients with Inflammatory Bowel Disease
23. The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease
24. Cross-sectional study of coronavirus disease 2019 (COVID-19) vaccine uptake among healthcare workers
25. Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended
26. Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
27. Seroresponse to Inactivated and Recombinant Influenza Vaccines among Maintenance Hemodialysis Patients
28. Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls
29. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine
30. Influenza vaccination rates and location for receiving the influenza vaccination among older adult Medicare beneficiaries
31. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD
32. 255 RACIAL AND GENDER DISPARITIES EXIST IN INFLUENZA VACCINATION RATES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
33. Fr552 RURAL-DWELLING PATIENTS WITH IBD HAVE LOWER INFLUENZA AND PNEUMOCOCCAL IMMUNIZATION RATES
34. What Gastroenterologists Should Know About COVID-19 Vaccines
35. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity
36. How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease
37. Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic
38. Erratum to: Optimizing Immunization Strategies in Patients with IBD
39. Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease
40. Timeliness of data entry in Wisconsin Immunization Registry by Wisconsin pharmacies
41. Vaccination in Patients With Inflammatory Bowel Disease
42. Influenza vaccination medical waivers among healthcare workers at an academic health system
43. Mo1812 THE BURDEN OF VACCINE-PREVENTABLE INFECTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
44. Sa1768 A MAJORITY OF YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE SUSTAINED IMMUNITY TO HEPATITIS B
45. Su1834 ACCURACY OF SELF-REPORTED VACCINATION STATUS IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
46. Optimizing Immunization Strategies in Patients with IBD
47. Zoster vaccine in immunosuppressed populations
48. Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin
49. Human papillomavirus immunization reduces the burden of disease in the community
50. The strength of the community: Herd protection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.